ITGA2 and pulmonary fibrosis: The compound has been suggested to reduce fibrosis because it either directly or together with an inhibitor of the main collagen receptor discoidin domain receptor 1 (DDR1) attenuated lung inflammation and fibroblast activation in idiopathic pulmonary fibrosis [81,87].